Thursday, May 10, 2018

Pharma Reviews: 'Indian IP and liabilities law barrier to pharma R&D investment'

BOSTON: India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that prevents ...
Read more: 'Indian IP and liabilities law barrier to pharma R&D investment'